K-PIO Tablets

For The Use Of A Registered Medical Practitioner, A Hospital Or A Laboratory Only.
COMPOSITION
K-PIO 15 mg Tablets
Each Uncoated Tablet Contains:
Pioglitazone HCl IP eq. to Pioglitazone 15 mg
K-PIO 30 mg Tablets
Each Uncoated Tablet Contains:
Pioglitazone HCl IP eq. to Pioglitazone 30 mg
INDICATIONS
K-PIO is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes (non-insulin-dependent diabetes mellitus, NIDDM). K-PIO is indicated for monotherapy. K-PIO is also indicated for use in combination with a sulfonylurea, metformin, or insulin when diet and exercise plus the single agent does not result in adequate glycemic control.
DOSAGE AND ADMINISTRATION
Oral: The recommended dose for K-PIO is 15-45 mg once daily without regard to meals.
HOW SUPPLIED
10 Tablets per strip.